Macrophage Function in the Elderly and Impact on Injury Repair and Cancer
Overview
Affiliations
Older age is associated with deteriorating health, including escalating risk of diseases such as cancer, and a diminished ability to repair following injury. This rise in age-related diseases/co-morbidities is associated with changes to immune function, including in myeloid cells, and is related to immunosenescence. Immunosenescence reflects age-related changes associated with immune dysfunction and is accompanied by low-grade chronic inflammation or inflammageing. This is characterised by increased levels of circulating pro-inflammatory cytokines such as tumor necrosis factor (TNF), interleukin (IL)-1β and IL-6. However, in healthy ageing, there is a concomitant age-related escalation in anti-inflammatory cytokines such as transforming growth factor-β1 (TGF-β1) and IL-10, which may overcompensate to regulate the pro-inflammatory state. Key inflammatory cells, macrophages, play a role in cancer development and injury repair in young hosts, and we propose that their role in ageing in these scenarios may be more profound. Imbalanced pro- and anti-inflammatory factors during ageing may also have a significant influence on macrophage function and further impact the severity of age-related diseases in which macrophages are known to play a key role. In this brief review we summarise studies describing changes to inflammatory function of macrophages (from various tissues and across sexes) during healthy ageing. We also describe age-related diseases/co-morbidities where macrophages are known to play a key role, focussed on injury repair processes and cancer, plus comment briefly on strategies to correct for these age-related changes.
Aufy M, Abd-Elkareem M, Mustafic M, Abdel-Maksoud M, Hakamy A, Baresova V PLoS One. 2024; 19(12):e0311760.
PMID: 39705219 PMC: 11661583. DOI: 10.1371/journal.pone.0311760.
Reisser Y, Hornung F, Hader A, Lauf T, Nietzsche S, Loffler B Elife. 2024; 13.
PMID: 39607755 PMC: 11604217. DOI: 10.7554/eLife.100433.
Mechanisms and treatment of atherosclerosis: focus on macrophages.
Zhang L, Li J, Kou Y, Shen L, Wang H, Wang Y Front Immunol. 2024; 15:1490387.
PMID: 39569201 PMC: 11576186. DOI: 10.3389/fimmu.2024.1490387.
Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation.
Granoski M, Fischer K, Hahn W, Sivaraj D, Kussie H, Quintero F Front Physiol. 2024; 15:1427113.
PMID: 39473610 PMC: 11518795. DOI: 10.3389/fphys.2024.1427113.
Noh J, Han H, Kim D, Giles E, Farnell Y, Wright G Front Immunol. 2024; 15:1357444.
PMID: 39221237 PMC: 11361940. DOI: 10.3389/fimmu.2024.1357444.